Structures by: Desper J.
Total: 512
Bis(2-methyl-3-((benzamide-3-yl)methyl)benzimidaol-1- yl)silver(i) (SbF6)
(C16H15N3O)2Ag(SbF6)
Dalton transactions (Cambridge, England : 2003) (2005) 14 2462-2470
a=9.2644(4)Å b=13.2045(6)Å c=14.2022(6)Å
α=74.5580(10)° β=81.7510(10)° γ=72.2750(10)°
Bis(4-((2-methylbenzimidazol-1-yl)methyl)benzamide) silver(i) BF4, H2O
(C16H15N3O)2(AgBF4)(O)3.4
Dalton transactions (Cambridge, England : 2003) (2005) 14 2462-2470
a=40.141(3)Å b=4.9633(5)Å c=18.6857(19)Å
α=90.00° β=96.855(6)° γ=90.00°
3-((2-methylbenzimidazol-1-yl)methyl)benzamide, Ag (AsF6)
(C16H15N3O)2Ag(AsF6)(CH4O)0.5
Dalton transactions (Cambridge, England : 2003) (2005) 14 2462-2470
a=11.8443(8)Å b=12.1157(7)Å c=13.3329(8)Å
α=66.333(3)° β=69.670(3)° γ=87.960(3)°
?DW-X-7-SEB 2-amino-5-(iodoethynyl)-pyrimidine
C6H4IN3
CrystEngComm (2017) 19, 1 11
a=7.6148(9)Å b=7.8988(8)Å c=24.473(3)Å
α=90.00° β=90.00° γ=90.00°
DW-Y-2 2-amino-5-ethynylpyrimidine
C6H5N3
CrystEngComm (2017) 19, 1 11
a=4.3404(7)Å b=7.7073(12)Å c=8.6344(15)Å
α=90.00° β=91.363(9)° γ=90.00°
DW-Y-8 (2-amino-5-ethynylpyrimidine)2, 2,3,5,6-Me4-pyrazine
(C6H5N3)2(C8H12N2)
CrystEngComm (2017) 19, 1 11
a=5.7849(18)Å b=6.0656(18)Å c=14.756(5)Å
α=79.742(8)° β=88.831(8)° γ=80.342(7)°
DW-X-4 [2-amino-5-(iodoethynyl)-pyrimidine]2, 1,2-bis(4-pyridyl)ethylene
(C6H4IN3)2(C12H10N2)
CrystEngComm (2017) 19, 1 11
a=19.625(2)Å b=7.5472(7)Å c=8.2583(8)Å
α=90.00° β=100.950(4)° γ=90.00°
DW-Y-4 2-amino-5-ethynylpyrimidine, (1,2-bis(4-pyridyl)ethylene)2
(C6H5N3)2(C12H10N2)
CrystEngComm (2017) 19, 1 11
a=5.9068(6)Å b=11.5286(12)Å c=15.8169(16)Å
α=104.471(4)° β=93.042(5)° γ=95.934(4)°
Mp-p1B-H5 F5-I-benzene, [1,2,3]Triazolo[1,5-a]quinoline
(C6F5I)(C10H7N3)
CrystEngComm (2016) 18, 44 8631
a=7.8304(9)Å b=15.1834(18)Å c=12.9152(15)Å
α=90.00° β=103.176(5)° γ=90.00°
Mp-p1b-Hb7 1,4-diiodotetrafluorobenzene, ([1,2,3]Triazolo[1,5-a]quinoline)2
(C6F4I2)(C10H7N3)2
CrystEngComm (2016) 18, 44 8631
a=6.6906(14)Å b=9.568(2)Å c=10.618(2)Å
α=64.954(6)° β=79.728(5)° γ=87.328(5)°
Mp-p1b-H11 {[1,2,3]Triazolo[1,5-a]quinoline}2, HOOC-(CH2)4-COOH
(C10H7N3)2(C6H10O4)
CrystEngComm (2016) 18, 44 8631
a=6.9843(6)Å b=25.501(2)Å c=6.8129(6)Å
α=90.00° β=108.111(4)° γ=90.00°
Mp-p1b-H21 [1,2,3]Triazolo[1,5-a]quinoline, 2-F-PhCOOH
(C10H7N3)(C7H5O2F)
CrystEngComm (2016) 18, 44 8631
a=6.3976(15)Å b=20.616(5)Å c=10.876(3)Å
α=90.00° β=98.126(9)° γ=90.00°
Mp-p1b-H15 {[1,2,3]Triazolo[1,5-a]quinoline}2, HOOC-(CH2)3-COOH
(C10H7N3)2(C5H8O4)
CrystEngComm (2016) 18, 44 8631
a=28.065(11)Å b=36.966(14)Å c=4.2708(16)Å
α=90.00° β=90.00° γ=90.00°
Mp-p1b-H28 [1,2,3]triazolo[1,5-a]pyridine, 1,2-diiodotetrafluorobenzene
(C6H5N3)(C6F4I2)
CrystEngComm (2016) 18, 44 8631
a=8.1237(17)Å b=7.1542(15)Å c=12.318(3)Å
α=90° β=92.502(7)° γ=90°
EK-B-Mal (3-pyridyl)-CONH-N=CH-(4-pyridyl), HOOC-(CH2)-COOH
(C12H10N4O)(C3H4O4)
CrystEngComm (2017)
a=7.0290(10)Å b=10.5537(15)Å c=10.8826(15)Å
α=73.431(5)° β=76.424(5)° γ=71.357(5)°
EK-A-Pim (2-pyridyl)-CONH-N=CH-(3-pyridyl), HOOC-(CH2)5-COOH
(C12H10N4O)(C7H12O4)
CrystEngComm (2017)
a=5.5981(7)Å b=45.389(5)Å c=7.3036(8)Å
α=90.00° β=98.469(5)° γ=90.00°
EK-D-Sub [(4-pyridyl)-CONH-N=CH-(2-pyridyl)]2, HOOC-(CH2)6-COOH dihydrate
(C12H10N4O)2(C8H14O4)(H2O)2
CrystEngComm (2017)
a=6.6774(11)Å b=8.2196(14)Å c=15.972(3)Å
α=81.888(7)° β=83.771(8)° γ=74.805(7)°
EK-B-Glu (3-pyridyl)-CONH-N=CH-(4-pyridyl), HOOC-(CH2)3-COOH dihydrate
(C12H10N4O)(C5H8O4)(H2O)2
CrystEngComm (2017)
a=10.9929(10)Å b=11.4742(10)Å c=16.1087(14)Å
α=102.095(3)° β=108.567(4)° γ=95.615(3)°
EK-B-Suc 3-pyridyl-CONH-N=CH-(3-pyridyl), HOOC-(CH2)2-COOH
(C12H10N4O)(C4H6O4)(H2O)
CrystEngComm (2017)
a=7.1160(8)Å b=13.0840(16)Å c=36.062(5)Å
α=90.00° β=90.00° γ=90.00°
EK-D-Adp [(4-pyridyl)-CONH-N=CH-(2-pyridyl)]2, HOOC-(CH2)4-COOH dihydrate
(C12H10N4O)2(C6H10O4)(H2O)2
CrystEngComm (2017)
a=6.5986(6)Å b=8.0173(8)Å c=15.3396(14)Å
α=97.862(4)° β=101.861(3)° γ=104.541(3)°
EK-A-Azl (2-pyridyl)-CONH-N=CH-(3-pyridyl), HOOC-(CH2)7-COOH
(C12H10N4O)(C9H16O4)
CrystEngComm (2017)
a=8.5041(12)Å b=9.6723(14)Å c=14.013(2)Å
α=80.742(6)° β=81.368(6)° γ=68.770(5)°
EK-C-Dod (3-pyridyl)-CONH-N=CH-(3-pyridyl), HOOC-(CH2)10-COOH hydrate
(C12H10N4O)(C12H22O4)(H2O)
CrystEngComm (2017)
a=6.9300(8)Å b=7.8773(10)Å c=24.680(3)Å
α=85.562(6)° β=83.394(6)° γ=66.198(5)°
EK-C-Seb (3-pyridyl)-CONH-N=CH-(3-pyridyl), HOOCH-(CH2)8-COOH hydrate
(C12H10N4O)(C10H18O4)(H2O)
CrystEngComm (2017)
a=6.9504(10)Å b=14.170(2)Å c=23.788(3)Å
α=79.555(9)° β=84.610(8)° γ=89.821(9)°
EK-D-Azl [(4-pyridyl)-CONH-N=CH-(2-pyridyl)]2, HOOC-(CH2)7-COOH dihydrate
(C12H10N4O)2(C9H16O4)(H2O)2
CrystEngComm (2017)
a=36.802(8)Å b=7.2815(14)Å c=12.533(3)Å
α=90.00° β=92.978(8)° γ=90.00°
EK-A-Glu (2-pyridyl)-CONH-NHCO-(3-pyridyl), HOOC-(CH2)3-COOH
(C12H10N4O)(C5H8O4)
CrystEngComm (2017)
a=20.694(3)Å b=5.5714(8)Å c=14.954(2)Å
α=90.00° β=105.047(7)° γ=90.00°
EK-A-Mal (2-pyridyl)-CONH-N=CH-(3-pyridyl), HOOC-(CH2)1-COOH
(C12H10N4O)(C3H4O4)
CrystEngComm (2017)
a=8.0953(12)Å b=9.9439(14)Å c=10.1459(15)Å
α=99.924(6)° β=106.674(6)° γ=100.865(6)°
C10H12O2,H2O
C10H12O2,H2O
New Journal of Chemistry (2018) 42, 13 10539
a=9.9472(12)Å b=6.1399(8)Å c=16.775(2)Å
α=90° β=104.248(2)° γ=90°
TW-2B-4 1,1'-di[(2-pyridyl)methyl]-2,2'-biimidazole, HOOC-(CH2)8-COOH
(C18H16N6)(C10H18O4)
New J. Chem. (2015) 39, 2 822
a=5.2731(8)Å b=7.8464(11)Å c=17.163(3)Å
α=81.964(6)° β=88.938(6)° γ=72.499(6)°
TW-2B-8-C 1,1'-di[(2-pyridyl)methyl]-2,2'-biimidazole, [HOOC-(CH2)5-COOH]2
(C18H16N6)(C7H12O4)2
New J. Chem. (2015) 39, 2 822
a=4.9161(10)Å b=8.0077(16)Å c=20.828(4)Å
α=87.266(11)° β=88.665(10)° γ=72.608(9)°
4-(2-imidazolyl)-pyridine, silver(I)
(C8H6N3)Ag
New Journal of Chemistry (2013) 37, 1 204
a=6.4496(5)Å b=13.5953(11)Å c=8.6168(6)Å
α=90.00° β=94.244(3)° γ=90.00°
TW-SC-2 2,3,5,6-Me4-pyrazine-1,4-dioxide, I-(CF2)2-I
(C8H12N2O2)(C2F4I2)
Chemical communications (Cambridge, England) (2015) 51, 12 2425-2428
a=8.6275(16)Å b=12.005(2)Å c=8.3466(15)Å
α=90.00° β=118.080(5)° γ=90.00°
3-nitrobenzoic acid, isonicotinamide
(C7H5NO4)(C6H6N2O)
CrystEngComm (2004) 6, 5 19-24
a=5.9827(4)Å b=9.1713(8)Å c=12.1893(8)Å
α=84.149(5)° β=77.407(6)° γ=74.927(5)°
D8 2-aminopyrazine, HOOC-(CH2)3-COOH
(C4H5N3)(C5H8O4)
CrystEngComm (2012) 14, 18 5845
a=5.2487(3)Å b=29.2633(18)Å c=7.2357(5)Å
α=90.00° β=104.958(3)° γ=90.00°
SF228 (3-pyridyl)-CONH-N=CH-(2-pyridyl), 3-fluorobenzoic acid
(C12H10N4O)(C7H5FO2)(H2O)
CrystEngComm (2012) 14, 7 2435
a=6.6065(14)Å b=7.2295(17)Å c=21.354(4)Å
α=92.457(13)° β=97.668(14)° γ=116.706(15)°
SF807 [(4-pyridyl)-CONH-N=CH-(4-pyridyl)], hexanedioic acid hydrate
(C12H10N4O)(C6H10O4)(H2O)
CrystEngComm (2012) 14, 7 2435
a=6.8908(3)Å b=11.3841(6)Å c=12.6504(6)Å
α=66.395(2)° β=89.086(2)° γ=84.907(2)°
242 (3-pyridyl)-CONH-N=CH-(2-pyridyl), hexanoic acid hydrate
(C12H10N4O)(C6H12O2)(H2O)
CrystEngComm (2012) 14, 7 2435
a=6.6573(13)Å b=8.1256(14)Å c=18.128(3)Å
α=95.391(10)° β=97.999(12)° γ=104.439(14)°
3,3'-AzoPy 1-HB-XB (3-pyridyl)-N=N-(3-pyridyl), (4-I-F4- PhCOOH)2
(C10H8N4)(C7HF4IO2)2
CrystEngComm (2013) 15, 16 3125
a=4.9020(3)Å b=21.4561(12)Å c=12.1298(7)Å
α=90.00° β=100.151(2)° γ=90.00°
3,3'-AzoPy 5-HBXB (3-pyridyl)-N=N-(3-pyridyl), (4-Br-F4-PhCHO oxime)2
(C10H8N4)(C7H2BrF4NO)2
CrystEngComm (2013) 15, 16 3125
a=8.3500(8)Å b=8.3646(8)Å c=9.8996(10)Å
α=105.765(3)° β=103.151(3)° γ=99.733(3)°
4,4'-AzoPy 1-HB-XB (4-pyridyl)-N=N-(4-pyridyl), (4-I-F4- PhCOOH)
(C10H8N4)(C7HF4IO2)
CrystEngComm (2013) 15, 16 3125
a=6.2112(8)Å b=8.1879(11)Å c=8.9824(12)Å
α=84.843(3)° β=70.837(3)° γ=77.402(3)°
4,4'-AzoPy 8HBXB (4-pyridyl)-N=N-(4-pyridyl), 4-I-F4-PhCHO oxime
(C10H8N4)(C7H2F4INO)
CrystEngComm (2013) 15, 16 3125
a=17.6282(7)Å b=6.3167(3)Å c=31.7318(14)Å
α=90.00° β=96.518(2)° γ=90.00°
4,4'-AzoPy 4-HBXB (4-pyridyl)-N=N-(4-pyridyl), 4-Br-F4-PhOH
(C10H8N4)(C6HBrF4O)
CrystEngComm (2013) 15, 16 3125
a=6.3706(3)Å b=9.5670(5)Å c=13.3289(7)Å
α=79.453(2)° β=83.090(2)° γ=79.4760(10)°
(3-pyridyl)-N=N-(3-pyridyl), HOOC-(CH2)4-COOH
(C10H8N4)(C6H10O4)
CrystEngComm (2013) 15, 3 463
a=5.2025(4)Å b=7.0703(6)Å c=11.4579(10)Å
α=99.247(5)° β=102.957(6)° γ=101.395(5)°
05:04BD (4-pyridyl)-N=N-(4-pyridyl), HOOC-(CH2)6-COOH
(C10H8N4)(C8H14O4)
CrystEngComm (2013) 15, 3 463
a=5.8269(6)Å b=8.6817(8)Å c=9.0827(9)Å
α=76.314(6)° β=87.963(6)° γ=77.486(6)°
(2,2-bis(benzanthracenol imine)binaphthyl Zn(ii))2 (CH2CL2)2 (Et2O)
(C58H34N2O2Zn)2(C1H2Cl2)2(C4H10O)
Dalton transactions (Cambridge, England : 2003) (2007) 15 1520-1527
a=12.5693(17)Å b=32.926(4)Å c=12.6967(17)Å
α=90.00° β=119.512(2)° γ=90.00°
DW-X-8-DOD [2-amino-5-(iodoethynyl)-pyrimidine]2, 2,3,5,6-Me4-pyrazine
(C6H4IN3)2(C8H12N2)
CrystEngComm (2017) 19, 1 11
a=5.7837(5)Å b=6.1130(5)Å c=16.4016(14)Å
α=98.086(4)° β=92.180(4)° γ=101.892(4)°
Mp-p1b-H10 [1,2,3]Triazolo[1,5-a]quinoline
C10H7N3
CrystEngComm (2016) 18, 44 8631
a=10.9465(10)Å b=8.6731(8)Å c=50.527(5)Å
α=90.00° β=93.861(4)° γ=90.00°
Mp-p1b-H24 {[1,2,3]Triazolo[1,5-a]quinoline}2, 4-I-F4-PhCOOH
(C10H7N3)2(C7HF4IO2)
CrystEngComm (2016) 18, 44 8631
a=6.6580(8)Å b=9.8155(11)Å c=10.4663(13)Å
α=65.256(4)° β=79.993(4)° γ=84.833(4)°
Mp-p1b-H29 [1,2,3]Triazolo[1,5-a]pyridine, 1,3,5-F3-2,4,6-I3-benzene
(C6H5N3)(C6F3I3)
CrystEngComm (2016) 18, 44 8631
a=9.3698(6)Å b=13.7351(9)Å c=12.2408(8)Å
α=90.00° β=90.6496(15)° γ=90.00°
EK-A-Adp [2-pyridyl-CONH-N=CH-(3-pyridyl)]2, HOOC-(CH2)4-COOH
(C12H10N4O)2(C6H10O4)
CrystEngComm (2017)
a=5.9660(5)Å b=7.2613(6)Å c=16.8960(14)Å
α=89.858(2)° β=80.013(3)° γ=79.638(2)°
A-2-6 CVT-COOH, 4,4'-bipyridyl
(C60H72O16)(C10H8N2)2(C2H3N)0.8(CH3OH)2(CH3O)1.2
CrystEngComm (2016) 18, 39 7457
a=29.225(3)Å b=11.4565(11)Å c=23.889(2)Å
α=90° β=99.091(5)° γ=90°
A-2-4 HOOC-CVT, 2-H2N-4-Cl-5-Br-6-H3C-pyrimidine
(C60H72O16)2(C5H5N3BrCl)3(H2O)4(C2H3N)8
CrystEngComm (2016) 18, 39 7457
a=14.7508(9)Å b=16.1947(10)Å c=17.6138(11)Å
α=75.197(2)° β=79.775(3)° γ=80.709(3)°
Copper(ii)(isonicotinamide)diacetate
(C10H12Cu1N2O5)(C2H3N)
Dalton Trans. (2003) 20 3956-3962
a=7.1996(10)Å b=8.1027(12)Å c=13.4485(19)Å
α=90.408(2)° β=96.328(3)° γ=96.118(2)°
Copper(ii)bis(isonicotinamide)bis(2-fluorobenzoate)
C26H24CuF2N4O8
Dalton Trans. (2003) 20 3956-3962
a=7.4814(12)Å b=7.7279(14)Å c=12.586(2)Å
α=72.762(3)° β=72.803(3)° γ=77.970(3)°
Copper(ii)(isonicotinamide)diacetate
C16H18CuN4O6,C1H4O,(C1H4O)0.25
Dalton Trans. (2003) 20 3956-3962
a=9.3053(17)Å b=10.1542(19)Å c=12.885(2)Å
α=69.735(3)° β=75.696(3)° γ=67.129(3)°
Copper(ii)bis(isonicotinamide)diacetate diacetic acid
C16H18CuN4O6,(C2H4O2)2
Dalton Trans. (2003) 20 3956-3962
a=11.0398(15)Å b=15.245(2)Å c=15.650(2)Å
α=90.00° β=104.910(3)° γ=90.00°
Bis(isonicotinamide)-bis(2-fluorobenzoate)(2-fluorobenzoic acid)copper(ii)
(C6H6N2O)2(C7H4O2F)2(C7H5O2F)Cu
Dalton Trans. (2003) 20 3956-3962
a=11.0792(14)Å b=19.771(2)Å c=15.5280(19)Å
α=90.00° β=104.284(3)° γ=90.00°
AS-15 2-(4-tolyl)-2,4-pentanedione
C12H14O2
Dalton transactions (Cambridge, England : 2003) (2011) 40, 45 12160-12168
a=7.5220(8)Å b=6.6202(7)Å c=11.1582(12)Å
α=90.00° β=108.875(4)° γ=90.00°
AS-14 2-(4-chlorophenyl)-2,4-pentanedione
C11H11ClO2
Dalton transactions (Cambridge, England : 2003) (2011) 40, 45 12160-12168
a=20.2258(14)Å b=6.7622(5)Å c=7.3688(5)Å
α=90.00° β=90.00° γ=90.00°
AS-5 2-(4-bromophenyl)-2,4-pentanedione
C11H11BrO2
Dalton transactions (Cambridge, England : 2003) (2011) 40, 45 12160-12168
a=20.4766(18)Å b=6.8070(6)Å c=7.3506(6)Å
α=90.00° β=90.00° γ=90.00°
PC-7-3-Iacac 2-(4-iodophenyl)-2,4-pentanedione
C11H11IO2
Dalton transactions (Cambridge, England : 2003) (2011) 40, 45 12160-12168
a=21.0708(12)Å b=6.9034(4)Å c=7.3624(4)Å
α=90.00° β=90.00° γ=90.00°
AS-12 2-(4-tolyl)-2,4-pentanedione, copper(II) tetrafluoroborate
(C12H13O2)2Cu
Dalton transactions (Cambridge, England : 2003) (2011) 40, 45 12160-12168
a=11.9427(6)Å b=16.3128(8)Å c=21.4984(11)Å
α=90.00° β=90.00° γ=90.00°
AS-6 bis[2-(4-bromophenyl)-2,4-pentanedionato]copper(II)
(C11H10BrO2)2(Cu)
Dalton transactions (Cambridge, England : 2003) (2011) 40, 45 12160-12168
a=12.0389(11)Å b=15.8409(12)Å c=22.1627(17)Å
α=90.00° β=90.00° γ=90.00°
D1 bis[2-(4-chlorophenyl)-2,4-pentanedionato]copper(II)
(C11H10ClO2)2Cu
Dalton transactions (Cambridge, England : 2003) (2011) 40, 45 12160-12168
a=11.9763(7)Å b=15.8265(9)Å c=21.7849(11)Å
α=90.00° β=90.00° γ=90.00°
AS-10 2-(4-iodophenyl)-2,4-pentanedione, copper(II) nitrate
(C11H10IO2)2Cu
Dalton transactions (Cambridge, England : 2003) (2011) 40, 45 12160-12168
a=8.2510(4)Å b=7.7262(4)Å c=17.8085(10)Å
α=90.00° β=101.525(3)° γ=90.00°
KO0802 Ni-benzoquinoline imine I
(C34H28N4)NiI2(CH2Cl2)
Dalton transactions (Cambridge, England : 2003) (2012) 41, 16 4998-5009
a=10.3765(12)Å b=24.333(3)Å c=13.5813(15)Å
α=90.00° β=104.936(5)° γ=90.00°
DP-2-74-1 quinoline cyclohexane imine Ni2 I4
C32H36I2N4Ni
Dalton transactions (Cambridge, England : 2003) (2012) 41, 16 4998-5009
a=14.9311(17)Å b=8.6427(9)Å c=25.050(3)Å
α=90.00° β=103.466(8)° γ=90.00°
DP-3-1-1 [1-(benzoquinoline imine)-2-amino-cyclohexane]2 Ni (OTf)2 (MeOH)
(C20H19N3)2Ni(CF3O3S)2(C2H6O)
Dalton transactions (Cambridge, England : 2003) (2012) 41, 16 4998-5009
a=12.3347(12)Å b=12.8896(13)Å c=17.0469(17)Å
α=86.5080(10)° β=73.8200(10)° γ=62.9640(10)°
DP-2-70-2 3,3'-bis(naphthoquinoline imine) binaphthyl Ni2 I4
(C48H30I4N4Ni2)(CHCl3)3
Dalton transactions (Cambridge, England : 2003) (2012) 41, 16 4998-5009
a=11.6896(8)Å b=22.8266(16)Å c=11.9341(9)Å
α=90.00° β=118.9240(10)° γ=90.00°
DP-2-96-1 cyclohexyl Ni quinoline imine Ni(OTf)
C64H72I3.20N8Ni2O0.80
Dalton transactions (Cambridge, England : 2003) (2012) 41, 16 4998-5009
a=43.3113(17)Å b=43.3113(17)Å c=10.1110(8)Å
α=90.00° β=90.00° γ=120.00°
1,2-bis(benzoquinoline imine) cyclohexane Ni I2, dichloromethane
(C34H28N4)(Ni2Cl1.85I2.15)(CH2Cl2)2.65
Dalton transactions (Cambridge, England : 2003) (2012) 41, 16 4998-5009
a=13.8504(14)Å b=14.2408(15)Å c=23.225(2)Å
α=90.00° β=90.00° γ=90.00°
DP-2-68-1
(C46H38I4N4Ni2)(CH2Cl2)1.6(O)1
Dalton transactions (Cambridge, England : 2003) (2012) 41, 16 4998-5009
a=12.1481(14)Å b=22.485(3)Å c=19.246(2)Å
α=90.00° β=90.00° γ=90.00°
EH-02-77-01 methoxy nitro propiony spiropyran Zn(ClO4)2
(C23H23N2O6)ZnCl
Dalton transactions (Cambridge, England : 2003) (2010) 39, 35 8269-8277
a=9.000(10)Å b=7.729(9)Å c=37.55(4)Å
α=90.00° β=94.774(8)° γ=90.00°
Isonicotinamide, I2
(C6H6N2O)(I2)
Chemical Communications (Cambridge, United Kingdom) (2007) 41 4236-4238
a=7.6928(10)Å b=7.7411(10)Å c=8.1841(11)Å
α=80.734(2)° β=72.131(2)° γ=85.702(2)°
KEDP1 3H-imidazo[4,5-b]pyridine, 1,3-diphenylurea
(C6H5N3)(C13H12N2O)
Chem.Commun. (2013) 49, 7929
a=24.508(3)Å b=19.467(3)Å c=6.9054(9)Å
α=90.00° β=102.327(6)° γ=90.00°
KEDP5 3H-imidazo[4,5-b]pyridine, 1,4-diiodotetrafluorobenzene
(C6H5N3)(C6F4I2)
Chem.Commun. (2013) 49, 7929
a=13.0356(7)Å b=23.2353(13)Å c=9.7061(6)Å
α=90.00° β=105.229(2)° γ=90.00°
KEDPU7 3H-imidazo[4,5-b]pyridine, N-phenyl-N-(4-bromophenyl)-urea
(C6H5N3)(C13H11BrN2O)
Chem.Commun. (2013) 49, 7929
a=13.5679(17)Å b=18.536(3)Å c=6.9157(9)Å
α=90.00° β=93.335(7)° γ=90.00°
KEDPX2 3H-imidazo[4,5-b]pyridine, 1,2-diiodotetrafluorobenzene
(C6H5N3)(C6F4I2)
Chem.Commun. (2013) 49, 7929
a=11.5283(11)Å b=14.7657(14)Å c=8.7953(8)Å
α=90.00° β=110.886(3)° γ=90.00°
C20H16N6O
C20H16N6O
Chem.Commun. (2013) 49, 7929
a=8.547(4)Å b=9.842(4)Å c=10.684(5)Å
α=76.349(9)° β=89.136(10)° γ=79.581(10)°
P60 2-aminopyrazine, 4-I-F4-PhCOOH
C4H5N3,C7HIF4O2
Chem.Commun. (2011) 47, 4688
a=15.2832(8)Å b=11.5421(6)Å c=15.3499(8)Å
α=90.00° β=107.171(2)° γ=90.00°
P59 2-aminopyrazine, 4-bromotetrafluorobenzoic acid
C4H5N3,C7HBrF4O2
Chem.Commun. (2011) 47, 4688
a=10.6236(4)Å b=10.6899(4)Å c=22.3295(9)Å
α=84.593(2)° β=76.279(2)° γ=90.002(2)°
PC-4-7b 2-amino-5-bromopyrazine, 4-I-F4-PhCOOH
C4H4BrN3,C7HF4IO2
Chem.Commun. (2011) 47, 4688
a=14.3341(10)Å b=14.1571(10)Å c=6.8919(5)Å
α=90.00° β=96.564(3)° γ=90.00°
P10 3-amino-2,6-dibromopyrazine, 4-I-F4-PhCOOH
C4H3Br2N3,C7HF4IO2
Chem.Commun. (2011) 47, 4688
a=10.4824(4)Å b=5.7580(3)Å c=25.7816(11)Å
α=90.00° β=98.9360(10)° γ=90.00°
P39 4-Br-2,3,5,6-F4-PhCOOH, 2-Br-5-NH2-pyrazine
C7HBrF4O2,C4H4BrN3
Chem.Commun. (2011) 47, 4688
a=7.1539(4)Å b=9.6066(5)Å c=10.2884(6)Å
α=89.546(4)° β=73.888(3)° γ=83.695(3)°
PC-4-7d 2-amino-3,5-dibromopyrazine, 4-Br-F4-PhCOOH
C4H3Br2N3,C7HBrF4O2
Chem.Commun. (2011) 47, 4688
a=15.2443(14)Å b=13.9577(16)Å c=21.995(3)Å
α=90.00° β=109.743(6)° γ=90.00°
621 4-carboxy-PhC(CN)=NOH, 1-((4-pyridyl)methyl)-5,6-Me2- benzimidazole
(C9H6N2O3)(C15H15N3)
Chemical communications (Cambridge, England) (2007) 38 3936-3938
a=11.0553(13)Å b=7.3121(9)Å c=13.2662(17)Å
α=90.00° β=94.693(7)° γ=90.00°
1-((4-pyridyl)methyl)-2-phenylimidazole, 4-hydroxybenzoic acid
(C15H13N3)(C7H6O3)
Chemical communications (Cambridge, England) (2007) 38 3936-3938
a=8.0137(8)Å b=9.8024(9)Å c=12.0784(13)Å
α=82.364(6)° β=86.045(7)° γ=75.888(6)°
442 1-((4-pyridyl)methyl)-5,6-dimethylbenzimidazole, 4- bromoPhC(CN)(=NOH)
C23H20BrN5O
Chemical communications (Cambridge, England) (2007) 38 3936-3938
a=15.9510(15)Å b=5.9914(6)Å c=23.071(2)Å
α=90.00° β=103.494(4)° γ=90.00°
1-(3-pyridylmethyl)benzimidazole, 3,5-diNO2PhCOOH, 3- Me2NPhCOOH
(C13H11N3)(C7H4N2O6)(C9H11NO2)
Chemical Communications (2005)
a=8.1324(7)Å b=10.8110(9)Å c=15.3761(13)Å
α=95.489(4)° β=90.318(5)° γ=91.503(5)°
1-(3-pyridylmethyl)-2-methyl-BzIm, 3,5-diNO2PhCOOH, 4- NO2PhCOOH
(C14H13N3)(C7H4N2O6)(C7H5NO4)
Chemical Communications (2005)
a=7.7318(8)Å b=7.0062(7)Å c=49.395(5)Å
α=90.00° β=91.012(6)° γ=90.00°
N-((3-pyridyl)methyl)benzimidazole, 4-NO2-PhCOOH, 3,5-di(NO2)- PhCOOH
(C13H11N3)(C7H5NO4)(C7H4N2O6)
Chemical Communications (2005)
a=7.7602(11)Å b=15.269(2)Å c=22.456(3)Å
α=82.064(3)° β=81.610(3)° γ=78.915(3)°
(C11H11N3O)(C7H6O2)
(C11H11N3O)(C7H6O2)
Chemical Communications (2006)
a=9.0434(8)Å b=10.5552(9)Å c=17.4323(15)Å
α=101.8070(10)° β=102.1260(10)° γ=94.3700(10)°
(C11H11N3O)2(C2H2O4)
(C11H11N3O)2(C2H2O4)
Chemical Communications (2006)
a=4.2359(8)Å b=49.029(9)Å c=5.5087(11)Å
α=90.00° β=92.780(4)° γ=90.00°
(C11H11N3O)2(C4H6O4)
(C11H11N3O)2(C4H6O4)
Chemical Communications (2006)
a=9.5363(9)Å b=7.3143(6)Å c=17.6580(15)Å
α=90.00° β=96.130(7)° γ=90.00°
(C11H11N3O)(C7H5O2F)
(C11H11N3O)(C7H5O2F)
Chemical Communications (2006)
a=4.3453(7)Å b=10.8147(17)Å c=34.003(5)Å
α=90.00° β=90.541(2)° γ=90.00°
KETA 1,3,5-tris-[CH(=NOH)]-benzene
C9H9N3O3
Chem.Commun. (2012) 48, 11289
a=16.6967(11)Å b=4.2787(3)Å c=13.1262(8)Å
α=90.00° β=90.00° γ=90.00°
AI5 cavitand
(C70H74N4O10BR2)(C3H6O)2(C6H14)0.5
Chem.Commun. (2011) 47, 11411
a=13.3457(7)Å b=19.5826(9)Å c=14.0550(8)Å
α=90.00° β=99.793(2)° γ=90.00°
AR-AI-11 pentyl (6-acetylamino-3-pyridyl)ethynyl cavitand
(C88H88N8O12)(C7H8)0.7(C2H5O1)3.4(C1H3O1)0.9(O1)0.5
Chem.Commun. (2011) 47, 11411
a=14.7722(7)Å b=15.9370(8)Å c=22.1716(11)Å
α=109.733(3)° β=96.094(3)° γ=93.890(3)°
(4-bromo-PhC(CN)(=NOH)), 3-bromo-5-methoxypyridine
(C8H5BrN2O)(C6H6BrNO)
CrystEngComm (2009) 11, 3 439-443
a=6.9907(6)Å b=8.0552(7)Å c=15.3027(13)Å
α=79.305(5)° β=89.038(5)° γ=64.660(5)°
(4-bromo-PhC(CN)(=NOH)), 1-(4-bromobenzyl)-2- methylbenzimidazole
(C8H5BrN2O)(C15H13BrN2)
CrystEngComm (2009) 11, 3 439-443
a=4.9374(6)Å b=22.597(3)Å c=19.233(2)Å
α=90.00° β=96.869(2)° γ=90.00°
(4-bromo-PhC(CN)(=NOH)), 1-(4-bromobenzyl)benzimidazole
(C8H5BrN2O)(C14H11BrN2)
CrystEngComm (2009) 11, 3 439-443
a=5.3033(6)Å b=13.2294(15)Å c=15.0601(17)Å
α=102.536(2)° β=99.505(2)° γ=94.752(2)°